Welcome to Hologic Investor Relations

Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems for breast and skeletal heath, GYN surgical products and medical aesthetic systems. With a broad range of market-leading technologies and a robust research and development program, Hologic is dedicated to The Science of Sure.

The Company's Common Stock is listed on the Nasdaq Global Select Market under the trading symbol HOLX.

Recent and Upcoming Events
Recent News
Apr 4, 2017

Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release its financial results for the second quarter of fiscal 2017 on Wednesday, May 10, 2017, after the market closes. In...

Apr 3, 2017

Hologic, Inc. (Nasdaq: HOLX) announced today that it has notified holders of the 2.00% Convertible Exchange Senior Notes due 2042 (CUSIP No. 436440 AC5) issued March 5, 2012, and Wilmington Trust...

Mar 22, 2017

Hologic, Inc. (Nasdaq: HOLX) announced today that it has completed the acquisition of Cynosure, Inc., a leader in medical aesthetics systems and technologies, for $66 per share in cash. "We are...

Mar 1, 2017

MARLBOROUGH, Mass., March 1, 2017 — Hologic, Inc. (Nasdaq: HOLX) will highlight its portfolio of innovative, award-winning breast cancer screening and interventional products, including new...

More ›